FCRL5 and COVID-19: Ogega et al. reported higher FcRL5 expression on RBD-specific class-switched memory B cells after non-severe COVID-19 (non-hospitalized patients) than after severe disease (hospitalized patients) [29], findings that are in agreement with our results.